Timely article ! I am back in MACK and AVEO, added ARIA significantly, also started SGYP due to major weakness from all four of them recently. MACK will have data points from several ph2 and ph3 trials in next 6-8 months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.